Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunity.
about
TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines.Targeting of CD122 enhances antitumor immunity by altering the tumor immune environment.The Imbalance of FOXP3/GATA3 in Regulatory T Cells from the Peripheral Blood of Asthmatic Patients.Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects
P2860
Combination GITR targeting/PD-1 blockade with vaccination drives robust antigen-specific antitumor immunity.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Combination GITR targeting/PD- ...... n-specific antitumor immunity.
@ast
Combination GITR targeting/PD- ...... n-specific antitumor immunity.
@en
type
label
Combination GITR targeting/PD- ...... n-specific antitumor immunity.
@ast
Combination GITR targeting/PD- ...... n-specific antitumor immunity.
@en
prefLabel
Combination GITR targeting/PD- ...... n-specific antitumor immunity.
@ast
Combination GITR targeting/PD- ...... n-specific antitumor immunity.
@en
P2093
P2860
P356
P1433
P1476
Combination GITR targeting/PD- ...... n-specific antitumor immunity.
@en
P2093
Daniel O Villarreal
Diana Chin
Leopoldo L Luistro
Linda A Snyder
Melissa A Smith
P2860
P304
39117-39130
P356
10.18632/ONCOTARGET.16605
P407
P577
2017-03-27T00:00:00Z